Radar · Life Sciences Tech in San Francisco
Best Life Sciences Tech Companies in San Francisco, United States
The 176 best Life Sciences Tech companies in San Francisco, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Xaira.
By Rohit KhannaTrends & Stories
176companies tracked
$6.4Bdisclosed funding
7unicorns
112have raised
FLIAR INTELLIGENCE · LIFE SCIENCES TECH × SAN FRANCISCO
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
89%cloud-native stacks
2025funding peak (by rounds)
8unicorns
2018median founding year
786kcombined LinkedIn audience
47%of audience held by top 3
7companies hiring publicly (12 mo)
Ranked: Best Life Sciences Tech companies in San Francisco
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Xaira 🦄 AI-enabled platform for drug discovery and development 55Funding top 22%Talent top 23%Moat top 26%Growth top 45% All 7 signals ▾Fundingtop 22% Talenttop 23% Moattop 26% Growthtop 45% Markettop 50% Techbottom 41% Globalbottom 36% Funding: Raised $1.0B across 1 rounds · 1 rounds over 2 yrs (0.5/yr) Talent: 5 named leaders on record · 5 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $1.0B | 25 mo ago | — | Robert Nelsen Co-Founder & Director | WebflowApple iCloud MailGoogle Workspace+12 | Top 5M | — | 1 job opening · 1 award |
| 2 | Insitro Developer of machine learning platform for drug discovery and development | $643M | 63 mo ago | 146 146 → 258 (+77%) · sector median +37% | Daphne Koller Founder and CEO | WordPressApple iCloud MailGoogle Workspace+20 | Top 10M | 164 patents AI-driven biomedical data analysis and disease modeling for drug discovery and diagnostics | — |
| 3 | Benchling 🦄 Provider of a cloud-based bioinformatics platform for biotech research | $412M | 55 mo ago | 500 500 → 810 (+62%) · sector median +37% | Ashu Singhal Co-Founder & President | ContentfulApple iCloud MailGoogle Workspace+31 | Top 1M | 15 patents Cloud-based bioprocess workflow and molecular design data management platform. | 1 job opening |
| 4 | Clarify 🦄 Company provides healthcare analytics and value-based payments platform services | $406M | 50 mo ago | 200 200 → 114 (-43%) · sector median +37% | Todd Gottula President and Co-founder | WordPressApple iCloud MailMicrosoft 365+39 | Top 10M | — | 2 partnerships |
| 5 | Innovaccer 🦄 Developer of healthcare data platforms and artificial intelligence agent software 93Funding top 23%Tech top 25%AI top 25%Moat top 25% All 13 signals ▾Fundingtop 23% Techtop 25% AItop 25% Moattop 25% Markettop 26% Fin. healthtop 28% Talenttop 28% Innovationtop 29% Patentstop 32% Growthtop 33% Producttop 38% Globaltop 42% Newsbottom 24% Funding: Raised $379M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Tech: 43 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Ses rank vs industry peers · Fliar Intelligence Index 93/100 | $379M | 17 mo ago | 1,003 1,003 → 1,712 (+71%) · sector median +37% | Abhinav Shashank Co-Founder & CEO | WebflowGSAPNginx+22 | Top 5M | 30 patents Integrating and analyzing de‑identified healthcare data across clouds for clinical decision support | 1 partnership |
| 6 | Verana Health Online platform for clinical trail data analytics and management software for researchers | $288M | 53 mo ago | 192 | Mark Blumenkranz Co-Founder & MD | WordPressApple iCloud MailMicrosoft 365+33 | Top 10M | — | — |
| 7 | Genesis Therapeutics Developer of an AI platform for discovering and designing novel drugs 48Funding top 23%Moat top 28%AI top 30%Tech top 35% All 9 signals ▾Fundingtop 23% Moattop 28% AItop 30% Techtop 35% Talenttop 38% Growthbottom 42% Globalbottom 37% Marketbottom 26% Newsbottom 21% Funding: Raised $280M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) Moat: Editorial + unicorn rating 8/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 48/100 | $280M | 19 mo ago | 10 | Ben Sklaroff Co-Founder & CTO | WordPressApple iCloud MailGoogle Workspace+19 | Top 10M | — | — |
| 8 | Viz.ai 🦄 Developer of an AI-powered platform for care coordination and disease detection | $252M | 38 mo ago | 206 206 → 327 (+59%) · sector median +37% | Chris Mansi Co-Founder & CEO | WordPressApple iCloud MailAlgolia+33 | Top 5M | 69 patents AI-powered clinical triage for stroke, aneurysm, and cardiac signal analysis | — |
| 9 | Frontier Medicines Developer of a bioinformatics platform for drug development and chemoproteomics | $236M | 27 mo ago | 119 119 → 78 (-34%) · sector median +37% | Roberto Zoncu Co-Founder | — | — | 60 patents KRAS G12C mutant inhibition using pyrido‑pyrimidine compounds for cancer therapy | — |
| 10 | Chai Discovery 🦄 Developer of artificial intelligence models for de novo molecular design 72Funding top 14%Talent top 28%AI top 30%Moat top 32% All 7 signals ▾Fundingtop 14% Talenttop 28% AItop 30% Moattop 32% Markettop 48% Globalbottom 48% Techbottom 42% Funding: Raised $230M across 3 rounds · 3 rounds over 2 yrs (1.5/yr) Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 72/100 | $230M | 6 mo ago | — | Joshua Meier Co-Founder | Framer SitesReactPriority Hints+7 | Top 10M | — | 1 partnership |
| 11 | Neuron23 AI-based drug discovery model for researchers 80Growth top 13%Funding top 18%Patents top 21%Moat top 21% All 10 signals ▾Growthtop 13% Fundingtop 18% Patentstop 21% Moattop 21% Innovationtop 23% AItop 45% Talentbottom 49% Globalbottom 40% Marketbottom 38% Newsbottom 18% Growth: Headcount 12 → 29 (+142%) across vintages · Fresh capital in last 24 mo Funding: Raised $214M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 80/100 | $214M | 11 mo ago | 29 29 → 28 (-3%) · sector median +37% | Adam Knight Founder & CBO | — | — | 49 patents LRRK2 kinase inhibitor therapeutics and biomarkers for Parkinson's disease treatment | 1 partnership |
| 12 | Atomwise Developer of artificial intelligence platform for small molecule drug discovery | $174M | 27 mo ago | 65 | — | WordPressApple iCloud MailGoogle Workspace+26 | Top 5M | 70 patents AI-driven discovery of small‑molecule inhibitors and virtual chemical library screening | — |
| 13 | Unlearn Developer of an AI platform for clinical trial design and analysis | $135M | 28 mo ago | 73 | Jonathan Walsh Founder | WebflowAmazon Web ServicesGSAP+20 | Top 5M | 50 patents AI-driven covariate adjustment and causal inference methods for clinical trial analytics | — |
| 14 | Verge Genomics Developer of artificial intelligence powered platform for drug discovery and development | $134M | 54 mo ago | 46 46 → 27 (-41%) · sector median +37% | Peyton Huang Non-Executive Director and Co-Founder | — | — | — | 1 launch · 1 partnership |
| 15 | Seer Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | 70 mo ago | 89 89 → 151 (+70%) · sector median +37% | — | WordPressSentryMySQL+28 | Top 10M | 201 patents Advanced bioanalytical platforms for protein, peptide, and biomolecule detection and characterization | — |
| 16 | Vineti Provider of clinical-to-commercial platform for cell and gene therapy supply chain management | $115M | 68 mo ago | 118 | Stephen Ting Co-Founder | — | — | 15 patents Digital platform integrating personalized therapy data, AI analytics, and smart labeling for individualized medicine | — |
| 17 | Aktana Provider of AI-powered solutions for healthcare provider engagement in life sciences | $91M | 68 mo ago | 285 | Jack O'Holleran ex-Co-Founder | — | — | 41 patents AI-driven omnichannel marketing and sales optimization platforms using contextual decision models | — |
| 18 | Noetik Developer of AI-driven platform for cancer immunotherapy discovery and development | $62M | 22 mo ago | — | Jacob Rinaldi Co-Founder & CSO | WebflowApple iCloud MailGoogle Workspace+10 | Top 10M | 2 patents Digital pathology image analysis for precision tissue microarray construction | 2 internships |
| 19 | NewLimit 🦄 Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension 62Funding top 22%Talent top 28%Growth top 35%AI top 45% All 9 signals ▾Fundingtop 22% Talenttop 28% Growthtop 35% AItop 45% Techtop 46% Moattop 47% Marketbottom 36% Globalbottom 36% Newsbottom 18% Funding: Raised $60.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 62/100 | $60M | 8 mo ago | 8 | Jacob Kimmel Co-Founder | SubstackSentryNode.js+13 | Top 10M | — | 4 job openings |
| 20 | Curebase Developer of software for clinical trial data and participant management | $59M | 49 mo ago | — | Storm Stillman Co-Founder & CEO | LovableReactReact Router+18 | Top 50M | — | — |
| 21 | Academia Social knowledge sharing platform for research scholars | $58M | 51 mo ago | 87 87 → 111 (+28%) · sector median +37% | — | SentryZendeskApple iCloud Mail+31 | Top 5k | — | — |
| 22 | Deep Apple Provider of drug candidate identification solutions for drug development | $52M | 30 mo ago | 12 | — | WordPressMySQLPHP+10 | Top 50M | — | — |
| 23 | Aizon Provider of AI-based software for manufacturing operations | $45M | 28 mo ago | 106 | Pere Merino Co-Founder & COO | WebflowApple iCloud MailGoogle Workspace+21 | Top 10M | — | — |
| 24 | Atomic AI Provider of AI based RNA drug discovery platform | $42M | 40 mo ago | 25 | Raphael Townshend Founder & CEO | WordPress Site EditorWordPressMySQL+11 | Top 10M | 15 patents AI-driven biopolymer/RNA structure prediction and secure data communication protocols | — |
| 25 | Glyphic Biotechnologies Developer of a platform for next-generation protein sequencing 50Patents top 25%Moat top 25%Innovation top 28%Funding top 28% All 8 signals ▾Patentstop 25% Moattop 25% Innovationtop 28% Fundingtop 28% Talentbottom 49% Techbottom 46% Globalbottom 40% Marketbottom 37% Patents: 35 patents matched (strict assignee match) · 35 filings since 2022 vs 0 in 2017-21 Moat: Editorial + unicorn rating 7/10 · IP moat: 35 patents rank vs industry peers · Fliar Intelligence Index 50/100 | $39M | 15 mo ago | 40 40 → 33 (-18%) · sector median +37% | Joshua Yang Co-Founder & CEO | WordPress Block EditorElementorWordPress+20 | Top 10M | 35 patents Innovative chemistries for single‑molecule protein/peptide sequencing using guanidinylation and polymerizable coupling. | — |
| 26 | Triomics Provider of clinical research and clinical trial tracking software 60AI top 20%Funding top 26%Talent top 38%Moat top 39% All 8 signals ▾AItop 20% Fundingtop 26% Talenttop 38% Moattop 39% Techtop 40% Growthtop 47% Globalbottom 43% Marketbottom 35% AI: Classified as an AI company Funding: Raised $28.9M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $29M | 0 mo ago | 29 | Hrituraj Singh Co-Founder & CTO | WixSentryEnvoy+20 | Top 10M | — | — |
| 27 | Uncountable Data Developer of a unified platform for research and development data management 62Talent top 22%Funding top 27%Growth top 35%Tech top 43% All 8 signals ▾Talenttop 22% Fundingtop 27% Growthtop 35% Techtop 43% Moattop 48% Productbottom 48% Marketbottom 43% Globalbottom 37% Talent: Analyst team rating 5/5 · 3 named leaders on record Funding: Raised $27.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $27M | 12 mo ago | 50 | Noel Hollingsworth Co-Founder | WebflowSalesforceVimeo+21 | Top 5M | — | — |
| 28 | Deep Origin AI-powered tools to accelerate drug discovery programs | $26M | 28 mo ago | — | Michael Antonov Co-Founder & CEO | WebflowMaterialize CSSAmazon Web Services+23 | Top 10M | — | 1 partnership |
| 29 | VeriSIM Life AI enabled biosimulation model for drug development 22Funding top 29%AI top 45%Talent bottom 49%Global bottom 37% All 7 signals ▾Fundingtop 29% AItop 45% Talentbottom 49% Globalbottom 37% Techbottom 28% Marketbottom 23% Newsbottom 22% Funding: Raised $21.4M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 22/100 | $21M | 11 mo ago | 13 13 → 19 (+46%) · sector median +37% | Jyotika Varshney Co-Founder & CEO | — | Top 50M | — | 1 award |
| 30 | Power Online platform to find clinical trials and treatments | $19M | 30 mo ago | 9 | Brandon Li Co-Founder | Node.jsReactNext.js App Router+11 | Top 500k | 256 patents Advanced liquid‑cooled power supplies and integrated PFC/DC‑DC conversion modules | — |
| 31 | IMIDomics Developer of medicines for the treatment of immune-mediated inflammatory diseases | $16M | 27 mo ago | 25 | Sara Marsal Co-Founder | — | — | — | — |
| 32 | General Proximity Developer of next generation of induced-proximity medicines 22Funding top 31%Talent bottom 49%Global bottom 48%Tech bottom 42% All 5 signals ▾Fundingtop 31% Talentbottom 49% Globalbottom 48% Techbottom 42% Marketbottom 24% Funding: Raised $16.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 22/100 | $16M | 1 mo ago | 11 | Armand Cognetta III Founder & CEO | WebflowVimeoGSAP+14 | Top 10M | — | — |
| 33 | Valinor Developer of machine learning models for clinical drug development acceleration 72Funding top 34%Talent top 38%AI top 45%Global bottom 48% All 4 signals ▾Fundingtop 34% Talenttop 38% AItop 45% Globalbottom 48% Funding: Raised $13.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 72/100 | $13M | 6 mo ago | — | Zhanel Nugmanova COO & Co-Founder | — | — | — | — |
| 34 | MiLaboratories Provider of a software platform for immune repertoire profiling | $12M | 20 mo ago | 14 | Stanislav Poslavsky Co-Founder & CEO | Amazon Web ServicesMailjetGoogle Workspace+5 | Top 50M | 8 patents Patents concentrated in computing, sensing & instrumentation | — |
| 35 | Korio Provider of software for clinical trial supply management | $12M | 21 mo ago | 4 | Chuck Harris Founder | WordPress Block EditorElementorWordPress+35 | Top 50M | — | 1 job opening |
| 36 | Peer AI Provider of an artificial intelligence to automate and streamline medical writing processes 80Patents top 18%Innovation top 22%AI top 28%Funding top 30% All 7 signals ▾Patentstop 18% Innovationtop 22% AItop 28% Fundingtop 30% Talenttop 45% Techbottom 49% Globalbottom 42% Patents: 62 patents matched (strict assignee match) · 62 filings since 2022 vs 0 in 2017-21 Innovation: 62 patents (top 17% of patent-holders) · 62 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 80/100 | $12M | 8 mo ago | — | Christopher Ceppi Co-Founder & COO | Framer SitesReactCloudflare+14 | Top 10M | 62 patents AR/VR portal systems enabling synchronized multi-user virtual environments and dynamic content placement | 1 job opening |
| 37 | Bluenote AI Platform offering job listings within the fashion industry | $10M | 17 mo ago | — | Fatima Sabar Co-Founder & CEO | — | — | — | — |
| 38 | Grove AI AI powered platform offering clinical trial management solutions | $10M | 17 mo ago | — | Tran Le Co-Founder & CEO | Framer SitesReactstyled-components+11 | Top 10M | 68 patents Telescopic crane jib designs and variable-position counterweight systems | — |
| 39 | Medeloop CRO focused on drugs discovery services | $8M | 20 mo ago | 18 | Rene Caissie Co-Founder & CEO | — | — | — | 2 launchs · 1 partnership |
| 40 | Blank Bio Developer of RNA foundation models for precision medicine research applications 60Talent top 28%Funding top 35%Global bottom 48% All 3 signals ▾Talenttop 28% Fundingtop 35% Globalbottom 48% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $7.2M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $7M | 1 mo ago | — | Jonathan Hsu Co-Founder & CEO | — | — | — | — |
| 41 | Mantis Provider of a cloud-based domain-aware data platform for life sciences 57Funding top 37%AI top 45%Global bottom 48%Talent bottom 45% All 4 signals ▾Fundingtop 37% AItop 45% Globalbottom 48% Talentbottom 45% Funding: Raised $6.3M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) AI: Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 57/100 | $6M | 7 mo ago | — | Georgia Witchel Founder & CEO | — | — | — | — |
| 42 | SynthioLabs Provider of AI agents for life sciences workflow acceleration | $6M | 7 mo ago | — | Rajashekar Vasantha Co-Founder | Radix UITailwind CSSshadcn/ui+8 | Top 10M | — | — |
| 43 | Luminate Health Provider of SaaS-based laboratory information management system | $5M | 23 mo ago | 9 | Jessica Hsu Co-Founder | WordPressMySQLPHP+18 | Top 50M | — | — |
| 44 | ScienceMachine Developer of an AI agent for biomedical data analysis and visualization | $4M | 11 mo ago | — | Lorenzo Sani Co-Founder | Node.jsAnimate.cssTailwind CSS+12 | Top 50M | — | — |
| 45 | Alixia Provider of cancer drug discovery and development platform | $2M | 23 mo ago | 5 | Helen Chen Co-Founder & CEO | — | — | — | — |
| 46 | Ditto Biosciences Developer of therapies targeting autoimmune diseases by leveraging parasite biology | $500K | 5 mo ago | — | Emily Weiss Co-Founder & CTO | — | — | — | — |
| 47 | Ritivel Developer of an AI regulatory platform for life sciences submissions | $500K | 5 mo ago | — | Pavan Tankala Co-Founder & CEO | TurbopackNode.jsTailwind CSS+10 | Top 50M | — | — |
| 48 | StrandAI Developer of AI to predict missing patient data modalities | $500K | 5 mo ago | — | Oded Falik Co-Founder & CTO | Node.jsThree.jsReact+10 | Top 50M | — | — |
| 49 | Frekil Online platform providing educational and research services in healthcare and medical imaging analytic | $500K | 12 mo ago | — | Shivesh Gupta CO-Founder & CTO | TurbopackNode.jsTailwind CSS+12 | Top 50M | — | — |
| 50 | Tamarind Bio Provider of a no-code bioinformatics platform for life scientists | $500K | 13 mo ago | — | Sherry Liu Co-Founder | Node.jsSalesforceClerk+14 | Top 1M | — | 1 partnership |
Top 12 Life Sciences Tech companies in San Francisco
#1
Series B · San Francisco, California · founded 2023$230Mraised▾
Series B · San Francisco, California · founded 2023
Developer of artificial intelligence models for de novo molecular design. The company focuses on engineering better molecules through advanced computational methods. It introduces new model series designed to achieve high hit rates in antibody design. The company provides access to its technology for molecular research and development.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 14%Talent
top 28%AI
top 30%Moat
top 32%Market
top 48%Global
bottom 48%Funding: Raised $230M across 3 rounds · 3 rounds over 2 yrs (1.5/yr) · Last round Series B (Dec 2025)
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
AI: Classified as an AI company · Product described with: artificial intelligence
Audience (LinkedIn): 18k LinkedIn followers — 2.3% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. Pfizer) announced in 12 mo
Funding rounds
- Dec 2025Series B$130M
- Aug 2025Series A$70M
- Sep 2024Seed$30M
Founders & team
Investors
Thrive Capital, OpenAI, Menlo Ventures, Anthropic, Yosemite, DST Global
Tech stack
CloudflareFramer SitesGoogle AnalyticsGoogle Font ApiGoogle WorkspaceHsts
#2
Series B · San Francisco, California · founded 2020 · 29 employees$28.9Mraised▾
Series B · San Francisco, California · founded 2020 · 29 employees
Provider of clinical research and clinical trial tracking software. The features of the software include an end-to-end platform for running clinical trials, unifying the workflows of clinical care and clinical research, and eliminating the operational inefficiencies in data collection, patient recruitment, and other laborious tasks involved in clinical research.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
AI
top 20%Funding
top 26%Talent
top 38%Moat
top 39%Tech
top 40%Growth
top 47%AI: Classified as an AI company
Funding: Raised $28.9M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) · Last round Series B (May 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding rounds
- May 2024Series B$15M
- Dec 2022Series A$13.8M
- 2021Seed$125K
Founders & team
Investors
Y Combinator, Nexus Venture Partners, General Catalyst, Lightspeed, Battery Ventures, Lightspeed Venture Partners
Tech stack
Amazon Web ServicesBootstrapCalendlyCloudflareCloudflare Bot ManagementCore-Js
#3
Seed · San Francisco, California · founded 2023 · 11 employees$16Mraised▾
Seed · San Francisco, California · founded 2023 · 11 employees
Developer of next generation of induced-proximity medicines. The company uses the OmniTAC drug discovery engine which yields molecules that co-opt existing cellular machinery to overcome exigent therapeutic challenges for oncology indications.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 31%Talent
bottom 49%Global
bottom 48%Tech
bottom 42%Market
bottom 24%Funding: Raised $16.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (May 2026)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Investors from 1 country beyond United States
Funding rounds
- May 2026Seed—
- Jan 2025Seed$16M
Founders & team
Investors
Y Combinator, age1, Modi Ventures, Wilson Sonsini Goodrich & Rosati, FreeMind Group, Daewoong Pharmaceutical
#4
Series D · San Francisco, California · founded 2018 · 29 employees$213.5Mraised▾
Series D · San Francisco, California · founded 2018 · 29 employees
AI-based drug discovery model for researchers. The company has developed software that assists with molecular targeting. It has features for precision medicine treatment, biological mechanisms, disease detection, and more. Company that focuses on developing precision medicines for genetically defined neurological and immunological diseases.
Fliar Intelligence Index™ 80how this company ranks against its industry peers
Growth
top 13%Funding
top 18%Patents
top 21%Moat
top 21%Innovation
top 23%AI
top 45%Growth: Headcount 12 → 29 (+142%) across vintages · Fresh capital in last 24 mo
Funding: Raised $214M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) · Last round Series D (Jun 2025)
Patents: 49 patents matched (strict assignee match) · 49 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 6k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Paradon's Foundation) announced in 12 mo
Funding rounds
- Jun 2025Series D$96.5M
- Mar 2022Series C$100M
- Dec 2020Series B$80M
- Dec 2020Series A$33.5M
Founders & team
Investors
SoftBank Vision Fund, Westlake Village Biopartners, Kleiner Perkins, Redmile Group, Cowen, HBM Partners
#5
NewLimit 🦄Series B · San Francisco, California · founded 2022 · 8 employees$60Mraised▾
NewLimit 🦄
Series B · San Francisco, California · founded 2022 · 8 employees
Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension. It focuses on restoring youthful function in old cells by reprogramming the epigenome. The company leverages technologies like single-cell genomics, machine learning, and high-throughput functional assays to identify epigenetic features of aging and discover interventions for rejuvenation. Its initial programs target the aging liver, immune, and vascular systems, with the long-term goal of significantly extending human healthspan through medicines for diseases associated with aging.
Fliar Intelligence Index™ 62how this company ranks against its industry peers
Funding
top 22%Talent
top 28%Growth
top 35%AI
top 45%Tech
top 46%Moat
top 47%Funding: Raised $60.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Oct 2025)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 14k LinkedIn followers
Hiring (LinkedIn): 4 hiring posts in 12 mo (public) · momentum +4 · hiring: Scientific Talent Partner, Scientist, Functional Genomics
Funding rounds
- Oct 2025Series B$45M
- May 2025Series B$130M
- May 2023Series A$72.2M
Founders & team
Investors
Dimension Venture Partners, Founders Fund, Kleiner Perkins, Khosla Ventures, Human Capital, Valor Equity Partners
Tech stack
CloudflareGoogle AnalyticsGoogle WorkspaceHstsHttp/3Jquery
#6
Seed · San Francisco, California · founded 2025$7.2Mraised▾
Seed · San Francisco, California · founded 2025
Developer of RNA foundation models for precision medicine research applications. The company builds models combining isoform, mutation, and expression signals from RNA. These models aim to improve patient stratification and boost diagnostic accuracy. Applications include patient stratification, enhanced diagnostics, target discovery, therapeutic design, and biosecurity monitoring. The company focuses on fine-tuning models for specific needs.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Talent
top 28%Funding
top 35%Global
bottom 48%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Funding: Raised $7.2M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (May 2026)
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. SymphoRNA (formerly Uncommon)) announced in 12 mo
Funding rounds
- May 2026Seed$7.2M
Founders & team
Investors
Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator
#7
Series F · San Francisco, California · founded 2014 · 1003 employees$378.6Mraised▾
Series F · San Francisco, California · founded 2014 · 1003 employees
Developer of healthcare data platforms and artificial intelligence agent software. This technology unifies clinical, operational, and financial information from disparate systems to support decision-making. The platform provides tools for population health management, revenue cycle automation, and quality performance tracking. It enables the deployment of automated assistants to streamline administrative workflows, manage patient outreach, and facilitate care coordination across various healthcare settings. The system integrates non-electronic health record data to improve documentation accuracy and support value-based care initiatives.
Fliar Intelligence Index™ 93how this company ranks against its industry peers
Funding
top 23%Tech
top 25%AI
top 25%Moat
top 25%Market
top 26%Fin. health
top 28%Funding: Raised $379M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Series F (Jan 2025)
Tech: 43 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Ses · Devops: Nginx
AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) · Product described with: artificial intelligence
Audience (LinkedIn): 258k LinkedIn followers — 32.8% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. Innovaccer) announced in 12 mo
Funding rounds
- Jan 2025Series F$178.8M
- Dec 2021Series E$150M
- Feb 2021Series D$105M
- Sep 2019Series C$70M
Founders & team
Investors
M12, Dragoneer Investment Group, Steadview, Schonfeld, Whale Rock Capital Management, Tiger Global Management
Tech stack
Amazon S3Amazon SesAmazon Web ServicesBabelBootstrapCalendly
#8
Series B · San Francisco, California · founded 2019 · 10 employees$280.1Mraised▾
Series B · San Francisco, California · founded 2019 · 10 employees
Developer of an AI platform for discovering and designing novel drugs. The platform is used to identify drug candidates against complex protein targets. It aims to create medicines with enhanced potency and selectivity. The platform integrates artificial intelligence with physics-based research. Scientists utilize the platform to advance breakthrough medicines.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Funding
top 23%Moat
top 28%AI
top 30%Tech
top 35%Talent
top 38%Growth
bottom 42%Funding: Raised $280M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) · Last round Series B (Nov 2024)
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 3 curated direct competitors tracked
AI: Classified as an AI company · Product described with: artificial intelligence
Audience (LinkedIn): 27k LinkedIn followers — 3.4% of this cohort's audience
Funding rounds
- Nov 2024Series B—
- Aug 2023Series B$224M
- Jun 2022Series A$23.9M
- Dec 2020Series A$52M
Founders & team
Investors
NVentures, Andreessen Horowitz, Fidelity Investments, BlackRock, Radical Ventures, Menlo Ventures
#9
Seed · San Francisco, California · founded 2024$13Mraised▾
Seed · San Francisco, California · founded 2024
Developer of machine learning models for clinical drug development acceleration. The company generates virtual patient profiles using multi-omics and clinical assay samples. It simulates therapeutic efficacy at the patient level. The company builds platforms to simulate therapeutic outcomes before trial enrollment.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 34%Talent
top 38%AI
top 45%Global
bottom 48%Funding: Raised $13.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (Dec 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
AI: Product described with: machine learning
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Renew Biotechnologies) announced in 12 mo
Funding rounds
- Dec 2025Seed$13M
Founders & team
Investors
CRV, Harpoon, Amino Collective, Pelion Venture Partners
#10
Series A · San Francisco, California · founded 2017 · 13 employees$21.4Mraised▾
Series A · San Francisco, California · founded 2017 · 13 employees
VeriSIM Life is developing software that uses AI-based disease-specific bio-simulation models for the drug development process as of March 2018. The pharma companies can use the software to predict the interaction of the drug in animals. A large number of drugs can be tested for their 'in vivo' properties using the software. The company claims that the software can reduce the cost and replace animal testing for the drug development process.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 29%AI
top 45%Talent
bottom 49%Global
bottom 37%Tech
bottom 28%Market
bottom 23%Funding: Raised $21.4M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) · Last round Grant (prize money) (Jul 2025)
AI: Product described with: ai-based
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 3k LinkedIn followers
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jul 2025Grant (prize money)$811.9K
- Apr 2022Grant (prize money)—
- Apr 2022Grant (prize money)$312.3K
- Jan 2022Series A$15M
Founders & team
Investors
America’s Seed Fund, Morpheus Ventures, OCA Ventures, Intel Capital, Serra Ventures, Susa Ventures
Tech stack
CdnjsCloudflareGoogle AnalyticsGoogle Tag ManagerJqueryJsdelivr
#11
Series B · San Francisco, California · founded 2023$12.1Mraised▾
Series B · San Francisco, California · founded 2023
Provider of an artificial intelligence to automate and streamline medical writing processess. It automating tasks such as data ingestion and enabling content creation. It delivering the path to automation for regulatory medical writing to pharmaceutical, biotechnology, CROs, and medical device companies. It automates the authoring of regulatory documents and adherence to compliance standards.
Fliar Intelligence Index™ 80how this company ranks against its industry peers
Patents
top 18%Innovation
top 22%AI
top 28%Funding
top 30%Talent
top 45%Tech
bottom 49%Patents: 62 patents matched (strict assignee match) · 62 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Innovation: 62 patents (top 17% of patent-holders) · 62 filings since 2022 vs 0 in 2017-21
AI: Holds AI/ML patents (G06N-family CPC) · Product described with: artificial intelligence
Audience (LinkedIn): 3k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Account Partner
Funding rounds
- Oct 2025Series B$12.1M
Founders & team
Investors
Flare Capital Partners, SignalFire, Greycroft, Atria Ventures, Alumni Ventures, Gaingels
Tech stack
CloudflareCloudflare Bot ManagementCookieyesCore-JsFramer SitesGoogle Analytics
#12
Series A · San Francisco, California · founded 2021 · 40 employees$39.2Mraised▾
Series A · San Francisco, California · founded 2021 · 40 employees
Developer of a platform for next-generation protein sequencing. The company is decoding the human proteome through de novo protein sequencing at single-molecule resolutions that enable researchers to gain novel insights into biology and disease.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Patents
top 25%Moat
top 25%Innovation
top 28%Funding
top 28%Talent
bottom 49%Tech
bottom 46%Patents: 35 patents matched (strict assignee match) · 35 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 7/10 · IP moat: 35 patents
Innovation: 35 patents (top 32% of patent-holders) · 35 filings since 2022 vs 0 in 2017-21
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Feb 2025Grant (prize money)$408.9K
- Dec 2024Series A—
- Feb 2024Series A$33.2M
- Sep 2023Grant (prize money)$767.9K
Founders & team
Investors
OMX Ventures, Osage University Partners, Wing Venture Capital, Artis Ventures, Civilization Ventures, Axial
Funding & investor landscape
$6.4Btotal disclosed funding
109companies funded
269disclosed rounds
2rounds last 90 days
Most active investors
Notable founders
Joshua Meier
Co-Founder · Chai Discovery
Jack Dent
Co-Founder · Chai Discovery
Hrituraj Singh
Co-Founder & CTO · Triomics
Sarim Khan
Co-Founder & CEO · Triomics
Armand Cognetta III
Founder & CEO · General Proximity
Adam Knight
Founder & CBO · Neuron23
Jacob Kimmel
Co-Founder · NewLimit
Brian Armstrong
Co-Founder · NewLimit
Jonathan Hsu
Co-Founder & CEO · Blank Bio
Ruian Shi
Co-Founder · Blank Bio
Abhinav Shashank
Co-Founder & CEO · Innovaccer
Sandeep Gupta
Co-Founder · Innovaccer
Prism market signals · United States · country-scoped Prism corpus, 2,593,976 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United States
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 42% across 2008–2026.
top research entities
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
leading researchers
Stylianos Chatzimanolis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Giannis Bolanakis · Ashley R Tetens · Tyler Findlay · Jordyn Craig-Schwartz
▲
Breakthroughs2,038 · 33%
▼ 41%→30% share
▼0.7× share momentum0 median citations71% since 2021mostly empirical
Gene-focused breakthrough research surged from 33 to 164 papers, now dominating the segment alongside newly emerging functional-biology sub-topics.
rising sub-themes (early→recent)
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
Newly emergingIdentification (biology) 0→18 · Function (biology) 0→18 · Reporter gene 0→16
Landmark U1 snRNP regulates cancer cell migration and invasion in vitro · 7,224 cites
◆
Advancements2,118 · 34%
▲ 29%→35% share
▲1.2× share momentum0 median citations80% since 2021mostly empirical
Cell culture and gene expression advancements intensified sharply — both rising from ~3 to 62 papers — as probiotic and cultivar topics newly emerged.
rising sub-themes (early→recent)
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
Newly emergingIdentification (biology) 0→27 · Probiotic 0→24 · Cultivar 0→23
Landmark Using Deep Learning for Image-Based Plant Disease Detection · 4,262 cites
▼
Concerns1,006 · 16%
▼ 17%→15% share
▼0.9× share momentum0 median citations73% since 2021mostly empirical
Antibiotic resistance concern papers tripled from 15 to 45, while animal health and integrated pest management newly entered the biotechnology risk landscape.
rising sub-themes (early→recent)
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Newly emergingQuality (philosophy) 0→27 · Animal health 0→14 · Integrated pest management 0→13
Landmark The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate · 8,812 cites
RESEARCH HOTSPOTS · United States
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Boston351 · +0.52
New York319 · +0.47
SF Bay Area235 · +0.57
Philadelphia115 · +0.60
San Diego101 · +0.59
Seattle95 · +0.46
Chicago95 · +0.57
Los Angeles93 · +0.61
Pittsburgh65 · +0.54
Ann Arbor65 · +0.58
PATENT SIGNAL · United States
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
457,918 filings8,000 assigneespeak 51616/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Genentech18103
- UNIV California17969
- Regeneron Pharma16083
- Amgen10510
- Monsanto Technology9754
- UNIV Pennsylvania8526
- Harvard College7463
- UNIV Texas7382
Common questions
How many Life Sciences Tech companies are there in San Francisco, United States?
Radar tracks 176 indexable Life Sciences Tech companies headquartered in San Francisco, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Tech companies in San Francisco, United States?
The Life Sciences Tech companies in San Francisco, United States on this list have raised a combined $6.4B in disclosed equity funding across 109 funded companies.
Which is the highest-funded Life Sciences Tech company in San Francisco, United States?
Xaira is the highest-funded Life Sciences Tech company in San Francisco, United States, with $1B in disclosed equity funding.
How many Life Sciences Tech companies in San Francisco, United States are funded?
109 of the 176 Life Sciences Tech companies in San Francisco, United States on this list have disclosed at least one equity funding round.
How many Life Sciences Tech unicorns are there in San Francisco, United States?
7 Life Sciences Tech companies in San Francisco, United States on this list are valued at $1B or more.
Who are the top investors in San Francisco, United States Life Sciences Tech companies?
The most active investors in San Francisco, United States Life Sciences Tech companies on this list include Y Combinator, DCVC, Lux Capital, Menlo Ventures, Khosla Ventures.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.